X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

World AIDS Day 2016: A decade of scientific innovation

By Andrew Powaleny  |    December 1, 2016
On World AIDS Day, we are reminded of the significant advances that have been made – many of which occurred over the past decade – to help transform HIV/AIDS from a once acutely fatal epidemic to...   Read More

10 years of living and managing type 1 diabetes; lessons learned

By Guest Contributor  |    November 30, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

ICER glosses over significant progress in MS treatment

By Holly Campbell  |    November 30, 2016
Multiple sclerosis (MS) is a devastating chronic autoimmune disease that can affect a person’s brain, spinal cord and optic nerves, causing problems with vision, balance, muscle control and other...   Read More

Medicare Monday: Open enrollment ends December 7! Last call to shop around

By Ashley Flint  |    November 28, 2016
This year’s Medicare open enrollment period is quickly coming to a close on December 7. Throughout the fall, we’ve shared resources for reviewing your plan options and making a selection and...   Read More

Medicare Monday: Progress in fight against diabetes is one more thing to be thankful for this year

By Nicole Longo  |    November 21, 2016
30 million. 1.4 million. 11 million. 86 million. These numbers on their own may mean nothing, but in the context of diabetes, they paint an entirely different picture. More than 30 million...   Read More

Reflecting on terrific progress in treating diabetes

By Bill Chin, M.D.  |    November 17, 2016
There is no doubt that diabetes is a complex disease to diagnose and treat. That’s something I’ve seen firsthand as an endocrinologist. Over the years, I treated a number of patients that had a...   Read More

Building on the promise of personalized medicine

By Andrew Powaleny  |    November 16, 2016
PhRMA’s member companies are on the leading edge of personalized medicine development– an area that is transforming health care, improving patient outcomes and creating health system efficiencies....   Read More

Continuing progress and promise in pediatric drug development

By Guest Contributor  |    November 15, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Medicare Monday: It’s important to shop around, even if your premium is decreasing next year

By Ashley Flint  |    November 14, 2016
During this year’s open enrollment period, which runs from October 15 to December 7, we’ve shared tools and resources to help you make your plan selection and discussed the benefits of switching...   Read More

New PhRMA report: More than 170 medicines in development for diabetes offer patients longer, healthier lives

By Hannah Mooney  |    November 14, 2016
Today, there are more than 30 million Americans suffering from type 1 or type 2 diabetes. Roughly 5 percent of patients have type 1 and 90 to 95 percent suffer from type 2, highlighting the...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates